Loading...
Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®
Quality by design (QbD) is an efficient but challenging approach for the development of biosimilar due to the complex relationship among process, quality, and efficacy. Here, the analytical similarity of adalimumab biosimilar HLX03 to Humira® was successfully established following a QbD quality stud...
Na minha lista:
| Udgivet i: | AAPS J |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7210234/ https://ncbi.nlm.nih.gov/pubmed/32385732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-020-00454-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|